Shire International Licensing BV – Trademark Portfolio
Entity Type: 03
Shire International Licensing BV holds 10 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 10 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 2 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include SHIRE, FOSRENOL, and F FOSRENOL. The owner is based in Amsterdam.
Olympic Plaza, Fred.
Amsterdam NL-1076EE , NL
Showing of trademarks Trademarks
Trademark Classifications
Shire International Licensing BV's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does Shire International Licensing BV have?
Shire International Licensing BV has 10 U.S. trademarks filed with the USPTO. Of these, 4 registered, 4 abandoned, 2 cancelled.
What trademark classes does Shire International Licensing BV file in?
Shire International Licensing BV files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Shire International Licensing BV's most well-known trademarks?
Shire International Licensing BV's registered trademark portfolio includes well-known marks such as SHIRE, FOSRENOL, and F FOSRENOL. These are among 4 currently registered trademarks in the portfolio.
What is Shire International Licensing BV's trademark registration success rate?
Shire International Licensing BV has a 40% trademark registration rate, with 4 out of 10 resolved applications resulting in successful registration. Currently, 0 applications are pending review.